Future Outlook: Treating Advanced Melanoma

Source: OncLive, February 2019


Axel Hauschild, MD: At the end of our discussion, I want to touch on 2 new components with different modes of action. There is the NKTR component, which is called NKTR-214. There was a trial released at ASCO [American Society of Clinical Oncology Annual Meeting] on this. Merrick, are you familiar with this data?

Merrick I. Ross, MD: No.

Axel Hauschild, MD: How about you, Jason?

read the original full article

2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder